PHIGENIX Trademark

Trademark Overview

On Wednesday, October 22, 2008, a trademark application was filed for PHIGENIX with the United States Patent and Trademark Office. The USPTO has given the PHIGENIX trademark a serial number of 77598154. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 19, 2012. The PHIGENIX trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical products for the prevention and treatment of cancers; Pharmaceutical preparations for the diagnosis of cancers

Pharmaceutical drug development services, Pharmaceutical research services

Medical services and pharmaceutical services, namely, dispensing of pharmaceuticals and diagnostic products
phigenix

General Information

Serial Number77598154
Word MarkPHIGENIX
Filing DateWednesday, October 22, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 19, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 28, 2009

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the word "PHIGENIX" with a DNA helix connected to the letter "P".
Goods and ServicesPharmaceutical products for the prevention and treatment of cancers; Pharmaceutical preparations for the diagnosis of cancers
Goods and ServicesPharmaceutical drug development services, Pharmaceutical research services
Goods and ServicesMedical services and pharmaceutical services, namely, dispensing of pharmaceuticals and diagnostic products

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 27, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 4, 2009
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 27, 2008
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressAtlanta, GA 30318
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressAtlanta, GA 30318

Trademark Events

Event DateEvent Description
Monday, November 19, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 19, 2012ABANDONMENT - NO USE STATEMENT FILED
Friday, March 30, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, March 29, 2012EXTENSION 5 GRANTED
Thursday, March 1, 2012EXTENSION 5 FILED
Thursday, March 1, 2012TEAS EXTENSION RECEIVED
Tuesday, October 25, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, October 24, 2011EXTENSION 4 GRANTED
Wednesday, October 19, 2011EXTENSION 4 FILED
Wednesday, October 19, 2011TEAS EXTENSION RECEIVED
Tuesday, April 26, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, April 25, 2011EXTENSION 3 GRANTED
Wednesday, April 20, 2011EXTENSION 3 FILED
Wednesday, April 20, 2011TEAS EXTENSION RECEIVED
Thursday, March 31, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 25, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 24, 2010EXTENSION 2 GRANTED
Wednesday, October 20, 2010EXTENSION 2 FILED
Tuesday, November 23, 2010EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, November 23, 2010PETITION TO REVIVE-GRANTED
Tuesday, November 23, 2010TEAS PETITION TO REVIVE RECEIVED
Monday, November 22, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 22, 2010ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 11, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 10, 2010EXTENSION 1 GRANTED
Tuesday, April 20, 2010EXTENSION 1 FILED
Monday, May 10, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 19, 2010TEAS EXTENSION RECEIVED
Tuesday, October 20, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 28, 2009PUBLISHED FOR OPPOSITION
Wednesday, July 8, 2009NOTICE OF PUBLICATION
Monday, June 22, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 19, 2009ASSIGNED TO LIE
Wednesday, June 17, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 17, 2009EXAMINER'S AMENDMENT ENTERED
Wednesday, June 17, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 17, 2009EXAMINERS AMENDMENT E-MAILED
Wednesday, June 17, 2009EXAMINERS AMENDMENT -WRITTEN
Monday, May 4, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 4, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 4, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 26, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 26, 2009NON-FINAL ACTION E-MAILED
Monday, January 26, 2009NON-FINAL ACTION WRITTEN
Monday, January 26, 2009ASSIGNED TO EXAMINER
Tuesday, October 28, 2008NOTICE OF DESIGN SEARCH CODE MAILED
Monday, October 27, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

phigenix pharmaceutical services cancers products medical diagnostic namely research dispensing pharmaceuticals